Submissions

Author Guidelines

Authors are invited to make a submission to this journal. All submissions will be assessed by an editor to determine whether they meet the aims and scope of this journal. Those considered to be a good fit will be sent for peer review before determining whether they will be accepted or rejected.

Before submitting, authors are responsible for obtaining permission to publish any material included with the submission, such as photos, documents and datasets. All authors identified on the submission must consent to be identified as an author. Where appropriate, research should be approved by an appropriate ethics committee by the legal requirements of the study's country.

An editor may reject a submission if it does not meet minimum standards of quality. Before submitting, please ensure that the study design and research argument are structured and articulated properly. The title should be concise and the abstract should be able to stand on its own. This will increase the likelihood of reviewers agreeing to review the paper. When you're satisfied that your submission meets this standard, please follow the checklist below to prepare your submission.

Interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to register with the journal before submitting or, if already registered, can simply log in and begin the five-step process.

Submission Guidelines

Authors interested in contributing to the SPJPP are encouraged to review the submission guidelines available on our website. These guidelines furnish detailed information on formatting, ethical considerations, and the submission process, ensuring a streamlined and transparent process.

Commitment to Excellence

As the editorial team, we are dedicated to upholding excellence and acting as a catalyst for the exchange of knowledge within the medical community. We invite you to explore the pages of SPJPP and join us in our mission to advance medical science and improve patient outcomes.

All manuscripts submitted for publication to the journal of SPJP should include the following details: 

• Cover Letter
• Title Page
• Manuscript File 
• Tables & Figures. 
• Undertaking by authors & copyright transfer agreement. 
• Ethical Confirmation (If Applicable)

TITLE PAGE

The title page should include (i) name(s) of the author(s); (ii) highest degree; (iii) name(s) of the Department(s); (iv) designations (academic position) of authors in the department; (v) complete postal addresses, mobile number and e-mail id of all authors; (vi) name of corresponding author with all above-mentioned details. All the content should be written in Times New Roman with font size 12, single-spaced, and justified.

The title page also should include: (i) Type of manuscript: original article/ review (ii) Title; (iii) Short title; (iv) Number of Tables; (v) Number of Figures; (vi) Source of financial support in the form of grants.

TYPE OF MANUSCRIPT

Original articles: Randomized controlled trials, interventions, screening and diagnostic test studies, outcome analyses, cost-effectiveness studies, case-control series, and surveys with high response rates are accepted (up to 3500 words). 

Review articles: Systematic critical assessments of literature and data sources are welcome (up to 5000 words). 

Pictorial essays: Descriptive essays primarily for teaching, richly illustrated with numerous figures, are accepted (up to 700 words).

Case reports: New, interesting, or very rare cases may be reported, with priority given to those with clinical significance or implications (up to 600 words). 

Brief Reports: Studies with limited statistical data, insufficient for an original study, can be presented with sections like Background, Methodology, Results, and Conclusion (up to 800 words).

Case Series: Reports on three or more cases with intriguing/new imaging findings or a novel interventional procedure are considered (up to 800 words).

Technical reports: Concise reports on unique or novel procedures or techniques of interest to readers (up to 500 words).

Letter to the Editor: Short letters related to a specific article or recent discussions in previous issues are accepted (up to 500 words). Announcements of conferences, meetings, courses, awards, and other relevant items should include contact information for additional details.

MANUSCRIPT FILE

Manuscripts must be submitted through the online submission portal only. Pages should be numbered consecutively, and the contents arranged in the following order:

• Title including Authors' Names (Full Name in Sequence) and Affiliation Details (Present Working Address with Designation), Email ID of All Authors/Co-Authors.
• Abstract
• Keywords
• Introduction
• Materials and Methods
• Statistical Analysis
• Results
• Discussion
• Conclusion
• Acknowledgement (If Applicable)
• Ethical statement.
• References

Title: The article's title should be brief, cohesive (avoiding broken or hyphenated titles), and simultaneously descriptive enough to facilitate indexing and information retrieval effectively. 

Abstract & Keywords: Except reviews, all manuscripts must include a structured abstract (approximately 250 words) with headings for Introduction & Objectives, Material and Methods, Results, and Discussion-Conclusions. The abstract should be concise, outlining the paper's scope and notable results. It should emphasize the primary findings and conclusions, enabling abstracting services to be used without alterations. A set of suitable keywords (3-5 in number) arranged alphabetically should also be provided.

Introduction: The Introduction or background should be concise, clearly outlining the paper's scope. When reviewing the literature, focus solely on the reasons for conducting the current study, offering essential background information. Clearly articulate the study's objective in this section, providing ample justification by the end.

Material & Methods: The article emphasizes comprehensive reporting standards for scientific research. It requires explicit mention of nomenclature, material and equipment sources, and procedures adopted, with a focus on enabling result reproducibility. Ethical standards for experiments on human subjects and animals, aligned with national guidelines, must be adhered to. Specific details on the care, use, and certification of laboratory animals are essential. Drugs and chemicals used should be precisely identified. Study design elements, including participant selection, sample size calculation, eligibility criteria, and study location, need clear articulation. Clinical trials must be registered, with registration numbers provided. Results from randomized clinical trials should detail study elements, masking methods, and statistical analyses, including significance levels. Standard statistical methods may reference established literature, while detailed descriptions are reserved for novel approaches.

Results: The result includes only essential data for understanding the study's discussion and main conclusions. The data should follow a coherent sequence, avoiding redundancy with tables and figures. Only significant observations should be emphasized, and duplication of data in both tabular and graphic forms should be avoided. Interpretation of the data is reserved for the Discussion section, not the Results section.

Discussion and Conclusion: The discussion section should interpret results without duplicating information from the results section. It should connect new findings to existing knowledge, make logical deductions, and acknowledge any study limitations. Conclusions should align with the study's goals, avoiding unsupported statements. Hypotheses, if present, must be identified, and recommendations can be included if deemed necessary and relevant within the discussion. The section is recommended to conclude with a summarizing remark.

Acknowledgement: It should be concise and reserved for specific scientific or technical assistance, excluding routine departmental facilities or general encouragement. Financial support or sponsorship from national or international funding agencies should be acknowledged.

Conflicts of Interest: A conflict of interest arises when authors or their institutions have financial or personal connections with individuals or organizations that may unduly impact their actions. Submissions must explicitly reveal any relationships that might be perceived as posing a potential conflict of interest. Authors are required to disclose all financial and personal associations that could potentially influence their work. If no conflicts of interest exist, authors should explicitly state this fact.

References: The maximum limit for references in Original Research Articles is typically set at 25, following the Vancouver style. References to cited literature should be sequentially numbered and positioned at the end of the manuscript. In the text, references should be indicated above the line (superior). Whenever possible, the mention of author names under references should be minimized.

TABLES & FIGURES:

Tables (and MS Word-format graphs) should be integrated into the main article file, numbered consecutively with Roman numerals. Tables should have concise titles, brief column headings, and abbreviated measurement units placed below the headings. Statistical variations such as SD and SE should be identified, and structural formulae in tables should be avoided. Abbreviations must be explained in footnotes. Figures, in JPEG format (not exceeding 1 MB), should be sequentially numbered with Arabic numerals, accompanied by appropriate titles and legend explanations. Multi-panel figures should be labelled A, B, C, etc. Photomicrographs should include internal scale markers, legible symbols, arrows, and letters, and graphs in JPEG or PDF format can be submitted as figures. Proper acknowledgement of published material and submission of copyright permissions are essential.

ABBREVIATIONS

Utilize only standard abbreviations adhering to the International System of Units (SI) in the text, tables, and figures. Prefer generic names for drugs; if proprietary brands are essential, include the brand name, manufacturer, and country in parentheses after the first use of the generic name. Ensure consistency throughout.

ETHICAL CLEARANCE CERTIFICATE

All research involving patients, volunteers, human biological material, or animals must provide a scanned copy of the Ethical Clearance Certificate.

UNDERTAKING BY AUTHOR(S) & COPYRIGHT TRANSFER AGREEMENT

All authors are required to submit a signed undertaking, following the journal's specified format, confirming their agreement to be listed as co-authors in the designated order on the title page. Each author should provide their name, affiliation, and position during the research, along with current contact details. If a junior author has left the institution, a senior author may sign on their behalf. Papers with corporate authorship must identify key individuals responsible, acknowledging other contributors separately. Authors will be requested to sign a copyright transfer agreement, granting the journal authority to address copyright infringements independently. This streamlines the process and avoids repeated author consultations.